WallStreetZenWallStreetZen

NYSEMKT: MTNB
Matinas Biopharma Holdings Inc Stock Ownership - Who owns Matinas Biopharma Holdings?

Insider buying vs selling

Have Matinas Biopharma Holdings Inc insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when MTNB insiders and whales buy or sell their stock.

MTNB Shareholders

What type of owners hold Matinas Biopharma Holdings Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Vanguard Group Inc3.72%9,317,838$1.43MInstitution
Adam K. Stern3.55%8,899,382$1.37MInsider
Herbert J. Conrad3.43%8,604,510$1.33MInsider
Sargent Investment Group LLC1.44%3,610,500$556.02kInstitution
Roelof Rongen1.41%3,539,416$545.07kInsider
Blackrock Inc0.99%2,482,400$382.29kInstitution
Geode Capital Management LLC0.85%2,135,457$328.86kInstitution
Jennifer Lorenzo0.83%2,086,576$321.33kInsider
Raphael J. Mannino0.77%1,919,715$295.64kInsider
Abdel A. Fawzy0.69%1,720,186$264.91kInsider

1 of 3

MTNB vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
MTNB10.15%11.91%
OCUP1.12%98.88%Net BuyingNet Buying
MRKR1.31%98.69%
LTRN10.20%65.57%Net SellingNet Selling
ATRA86.43%13.57%Net BuyingNet Selling

Matinas Biopharma Holdings Stock Ownership FAQ

Who owns Matinas Biopharma Holdings?

Matinas Biopharma Holdings (NYSEMKT: MTNB) is owned by 10.15% institutional shareholders, 11.91% Matinas Biopharma Holdings insiders, and 77.95% retail investors. Adam K. Stern is the largest individual Matinas Biopharma Holdings shareholder, owning 8.90M shares representing 3.55% of the company. Adam K. Stern's Matinas Biopharma Holdings shares are currently valued at $1.46M.

If you're new to stock investing, here's how to buy Matinas Biopharma Holdings stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.